142 related articles for article (PubMed ID: 32517036)
21. Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?
Vasudevan A; Gibson PR; van Langenberg DR
World J Gastroenterol; 2017 Sep; 23(35):6385-6402. PubMed ID: 29085188
[TBL] [Abstract][Full Text] [Related]
22. Alterations of the Subgingival Microbiota in Pediatric Crohn's Disease Studied Longitudinally in Discovery and Validation Cohorts.
Kelsen J; Bittinger K; Pauly-Hubbard H; Posivak L; Grunberg S; Baldassano R; Lewis JD; Wu GD; Bushman FD
Inflamm Bowel Dis; 2015 Dec; 21(12):2797-805. PubMed ID: 26288001
[TBL] [Abstract][Full Text] [Related]
23. Metabolomic Signatures in Pediatric Crohn's Disease Patients with Mild or Quiescent Disease Treated with Partial Enteral Nutrition: A Feasibility Study.
Marques JG; Shokry E; Frivolt K; Werkstetter KJ; Brückner A; Schwerd T; Koletzko S; Koletzko B
SLAS Technol; 2021 Apr; 26(2):165-177. PubMed ID: 33207993
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition-A Prospective Multicenter Study.
Blesl A; Wurm P; Waschina S; Gröchenig HP; Novacek G; Primas C; Reinisch W; Kutschera M; Illiasch C; Hennlich B; Steiner P; Koch R; Tillinger W; Haas T; Reicht G; Mayer A; Ludwiczek O; Miehsler W; Steidl K; Binder L; Reider S; Watschinger C; Fürst S; Kump P; Moschen A; Aden K; Gorkiewicz G; Högenauer C
Inflamm Bowel Dis; 2024 Jan; 30(1):9-19. PubMed ID: 37463118
[TBL] [Abstract][Full Text] [Related]
25. Take-Home Messages from 20 Years of Progress in Dietary Therapy of Inflammatory Bowel Disease.
Gkikas K; Svolos V; Hansen R; Russell RK; Gerasimidis K
Ann Nutr Metab; 2023; 79(6):476-484. PubMed ID: 37944498
[TBL] [Abstract][Full Text] [Related]
26. Fiber-deficient diet inhibits colitis through the regulation of the niche and metabolism of a gut pathobiont.
Kuffa P; Pickard JM; Campbell A; Yamashita M; Schaus SR; Martens EC; Schmidt TM; Inohara N; Núñez G; Caruso R
Cell Host Microbe; 2023 Dec; 31(12):2007-2022.e12. PubMed ID: 37967555
[TBL] [Abstract][Full Text] [Related]
27. Fiber-deficient diets reprogram the microbiota.
Fitzgerald BG; Sorbara MT
Cell Host Microbe; 2023 Dec; 31(12):1950-1951. PubMed ID: 38096786
[TBL] [Abstract][Full Text] [Related]
28. Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis.
Zeng W; Wu J; Xie H; Xu H; Liang D; He Q; Yang X; Liu C; Gong J; Zhang Q; Luo Z; Chen Y; He Z; Lan P
EBioMedicine; 2024 Feb; 100():104959. PubMed ID: 38215690
[TBL] [Abstract][Full Text] [Related]
29. "Out of the box" new therapeutic strategies for Crohn´s disease: moving beyond biologics.
Catalán-Serra I; Ricanek P; Grimstad T
Rev Esp Enferm Dig; 2023 Nov; 115(11):614-634. PubMed ID: 35748460
[TBL] [Abstract][Full Text] [Related]
30. Co-Development of Three Dietary Indices to Facilitate Dietary Intake Assessment of Pediatric Crohn's Disease Patients.
Harvey A.; Mannette J.; Sigall-Boneh R.; Macintyre B.; Parrott M.; Cahill L.; Connors J.; Otley A.; Haskett J.; van Limbergen J.; Grant S.
Can J Diet Pract Res; 2024 Apr; ():1-8. PubMed ID: 38634640
[TBL] [Abstract][Full Text] [Related]
31. JPEN Journal Club 83. Selecting trials to include in a systematic review.
Koretz RL
JPEN J Parenter Enteral Nutr; 2024 Mar; ():. PubMed ID: 38491963
[No Abstract] [Full Text] [Related]
32. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease.
Diederen K; Li JV; Donachie GE; de Meij TG; de Waart DR; Hakvoort TBM; Kindermann A; Wagner J; Auyeung V; Te Velde AA; Heinsbroek SEM; Benninga MA; Kinross J; Walker AW; de Jonge WJ; Seppen J
Sci Rep; 2020 Nov; 10(1):18879. PubMed ID: 33144591
[TBL] [Abstract][Full Text] [Related]
33. Influence of Enteral Nutrition on Gut Microbiota Composition in Patients with Crohn's Disease: A Systematic Review.
Horwat P; Kopeć S; Garczyk A; Kaliciak I; Staręga Z; Drogowski K; Mardas M; Stelmach-Mardas M
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32842543
[TBL] [Abstract][Full Text] [Related]
34. The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.
van Rheenen PF; Aloi M; Assa A; Bronsky J; Escher JC; Fagerberg UL; Gasparetto M; Gerasimidis K; Griffiths A; Henderson P; Koletzko S; Kolho KL; Levine A; van Limbergen J; Martin de Carpi FJ; Navas-López VM; Oliva S; de Ridder L; Russell RK; Shouval D; Spinelli A; Turner D; Wilson D; Wine E; Ruemmele FM
J Crohns Colitis; 2020 Oct; ():. PubMed ID: 33026087
[TBL] [Abstract][Full Text] [Related]
35. Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.
Effenberger M; Reider S; Waschina S; Bronowski C; Enrich B; Adolph TE; Koch R; Moschen AR; Rosenstiel P; Aden K; Tilg H
J Crohns Colitis; 2021 Jan; 15(1):88-98. PubMed ID: 32687146
[TBL] [Abstract][Full Text] [Related]
36. Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.
Clooney AG; Eckenberger J; Laserna-Mendieta E; Sexton KA; Bernstein MT; Vagianos K; Sargent M; Ryan FJ; Moran C; Sheehan D; Sleator RD; Targownik LE; Bernstein CN; Shanahan F; Claesson MJ
Gut; 2021 Mar; 70(3):499-510. PubMed ID: 32536605
[TBL] [Abstract][Full Text] [Related]
37. Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis.
Galipeau HJ; Caminero A; Turpin W; Bermudez-Brito M; Santiago A; Libertucci J; Constante M; Raygoza Garay JA; Rueda G; Armstrong S; Clarizio A; Smith MI; Surette MG; Bercik P; ; Croitoru K; Verdu EF
Gastroenterology; 2021 Apr; 160(5):1532-1545. PubMed ID: 33310084
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
39. Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?
Gkikas K; Gerasimidis K; Milling S; Ijaz UZ; Hansen R; Russell RK
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32645980
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Changes in Gut Microbiota in Patients with Crohn's Disease after Anti-Tnfα Treatment: Prospective Multicenter Observational Study.
Sanchis-Artero L; Martínez-Blanch JF; Manresa-Vera S; Cortés-Castell E; Rodriguez-Morales J; Cortés-Rizo X
Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32679874
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
